Albisser AM, Leibel BS, Ewart TG, et al. An artificial endocrine pancreas. Diabetes 1974;23:389-96.
Pfeiffer EF, Thum C, Clemens AH. The artificial beta cell- a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res 1974;6:339-42.
*Radermecker RP. Mesure continue du glucose dans la prise en charge du diabète: état des lieux et perspectives. Rev Med Suisse 2019;15:1444-7.
**Cobelli C, Renard E, Kovatchev B. Artificial pancreas: past, present, future. Diabetes 2011;60:2672-82.
Kowalski A, Lum JW. Juvenile diabetes research foundation artificial pancreas consortium update. J Diabetes Sci Technol 2009;3:1224-6.
*Brown SA, Kovatchev BP, Raghinaru D, et al. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med 2019;381:1707-17.
Lal RA, Ekhlaspour L, Hood K, Buckingham B. Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes. Endocr Rev 2019;40:1521-46.
Tauschmann M, Thabit H, Bally L, et al. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet 2018;392:1321-9.
Peters TM, Haidar A. Dual-hormone artificial pancreas: benefits and imitations compared with single-hormone systems. Diabet Med 2018;35:450-9.
**Bekiari E, Kitsios K, Thabit H, et al. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ 2018;361:k1310.
